Flex Work policy
Corporate Policy
Full time in office
About
Umoja Biopharma is a biotechnology company dedicated to developing transformative CAR-T cell therapies for the treatment of solid tumor cancers. Founded in 2019, the company focuses on in-vivo cell programming therapies, with a mission to leverage its technology to create a new generation of truly effective, accessible, and affordable cell medicines. Umoja Biopharma operates from its headquarters in Seattle, Washington.
This content was generated by A.I. Umoja Biopharma employees can
to make any changes.